Literature DB >> 16353286

Rapid prenatal diagnostic testing for Down syndrome only or longer wait for full karyotype: the views of pregnant women.

Mandy Ryan1, Jane Diack, Verity Watson, Norman Smith.   

Abstract

OBJECTIVES: Prenatal diagnosis by karyotype analysis determines the copy number and structure of each chromosome and is considered to be the 'gold standard' in detection of chromosome abnormality. This method is, however, time consuming and women may have to wait up to 21 days for the results. With improving molecular genetic techniques, the most commonly occurring chromosome abnormalities can be diagnosed within 2 days from amniotic fluid. This study investigates the value pregnant women place on these alternative prenatal diagnostic tests.
METHODS: A structured self-completion discrete choice experiment questionnaire was designed. The subjects were 40 pregnant women, of unknown risk, attending for their 11-week booking scan and 10 elevated-risk women attending for amniocentesis at the Aberdeen Maternity Hospital, Scotland.
RESULTS: Women value 'comprehensive' information of a full karyotype analysis at pounds 791, and 'simple' information of a rapid diagnostic test at pounds 690. Willingness to pay for a day's reduction in waiting time for results is pounds 18. Women prefer a prenatal service providing simple over comprehensive information as long as they receive results 6 days sooner than the comprehensive results would be provided.
CONCLUSIONS: While women prefer comprehensive information, the bulk of the value is placed on knowing whether the fetus has Down syndrome. Given the longer wait times for comprehensive information, simple information is preferred as long as results are received 6 days sooner than would be the case for comprehensive information. These results have implications for the resources dedicated to providing a rapid prenatal diagnostic service. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 16353286     DOI: 10.1002/pd.1309

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  12 in total

1.  Rapid aneuploidy detection or karyotyping? Ethical reflection.

Authors:  Antina de Jong; Wybo J Dondorp; Daniëlle R M Timmermans; Jan M M van Lith; Guido M W R de Wert
Journal:  Eur J Hum Genet       Date:  2011-06-01       Impact factor: 4.246

2.  Genetic testing in the European Union: does economic evaluation matter?

Authors:  Fernando Antoñanzas; R Rodríguez-Ibeas; M F Hutter; R Lorente; C Juárez; M Pinillos
Journal:  Eur J Health Econ       Date:  2011-05-20

3.  A Hierarchical Bayes Approach to Modeling Heterogeneity in Discrete Choice Experiments: An Application to Public Preferences for Prenatal Screening.

Authors:  Tima Mohammadi; Wei Zhang; Julie Sou; Sylvie Langlois; Sarah Munro; Aslam H Anis
Journal:  Patient       Date:  2020-04       Impact factor: 3.883

4.  Eliciting individual preferences for health care: a case study of perinatal care.

Authors:  Marjon van der Pol; Alan Shiell; Flora Au; David Jonhston; Suzanne Tough
Journal:  Health Expect       Date:  2009-08-18       Impact factor: 3.377

5.  Economic evaluation of multiplex ligation-dependent probe amplification and karyotyping in prenatal diagnosis: a cost-minimization analysis.

Authors:  Elisabeth M A Boormans; Erwin Birnie; Mariëtte J V Hoffer; Merryn V E Macville; Robert-Jan Galjaard; Gijsbertha H Schuring-Blom; Shama L Bhola; Karin Huijsdens; Arie Smits; Jan M M van Lith
Journal:  Arch Gynecol Obstet       Date:  2011-05-19       Impact factor: 2.344

6.  Willingness to participate in a lifestyle intervention program of patients with type 2 diabetes mellitus: a conjoint analysis.

Authors:  Paul F van Gils; Mattijs S Lambooij; Marloes Hw Flanderijn; Matthijs van den Berg; G Ardine de Wit; Albertine J Schuit; Jeroen N Struijs; B van den Berg
Journal:  Patient Prefer Adherence       Date:  2011-11-02       Impact factor: 2.711

7.  Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionals.

Authors:  Melissa Hill; Jo-Ann Johnson; Sylvie Langlois; Hyun Lee; Stephanie Winsor; Brigid Dineley; Marisa Horniachek; Faustina Lalatta; Luisa Ronzoni; Angela N Barrett; Henna V Advani; Mahesh Choolani; Ron Rabinowitz; Eva Pajkrt; Rachèl V van Schendel; Lidewij Henneman; Wieke Rommers; Caterina M Bilardo; Paula Rendeiro; Maria João Ribeiro; José Rocha; Ida Charlotte Bay Lund; Olav B Petersen; Naja Becher; Ida Vogel; Vigdis Stefánsdottir; Sigrun Ingvarsdottir; Helga Gottfredsdottir; Stephen Morris; Lyn S Chitty
Journal:  Eur J Hum Genet       Date:  2015-11-18       Impact factor: 4.246

8.  Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT).

Authors:  Caroline Savage Bennette; Susan Brown Trinidad; Stephanie M Fullerton; Donald Patrick; Laura Amendola; Wylie Burke; Fuki M Hisama; Gail P Jarvik; Dean A Regier; David L Veenstra
Journal:  Genet Med       Date:  2013-05-30       Impact factor: 8.822

9.  Preferences for Prenatal Tests for Cystic Fibrosis: A Discrete Choice Experiment to Compare the Views of Adult Patients, Carriers of Cystic Fibrosis and Health Professionals.

Authors:  Melissa Hill; Ranjan Suri; Edward F Nash; Stephen Morris; Lyn S Chitty
Journal:  J Clin Med       Date:  2014-02-14       Impact factor: 4.241

10.  Can we rely on the multiplex ligation-dependent probe amplification method (MLPA) for prenatal diagnosis?

Authors:  Mir Davood Omrani; Faezeh Azizi; Masoumeh Rajabibazl; Niloufar Safavi Naini; Sara Omrani; Arezo Mona Abbasi; Soraya Saleh Gargari
Journal:  Iran J Reprod Med       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.